MedPath

Ambipen

Brand Name: Ambipen

Generic Name: Ampicillin (as Sodium)

Active
Registration Number

DRP-5091

Dosage Form

Powder For Injection (Im/Iv)

Issuance Date

August 1, 2023

Expiry Date

February 12, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mg
PackagingUSP Type III clear glass vial with butyl rubber stopper (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Penicillin)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ampicillin (as Sodium)Active
Monograph: Ampicillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform